Abstract: The present disclosure provides rare earth die steel. Mg and B elements are added on the basis of adding rare earth element Y, so that the rare earth element purifies a matrix, and grain boundary occupation by Mg and B is fully utilized to regulate grain network chromium carbides. In addition, the B element can fully improve hardenability of austenite and ensure that non-martensite such as bainite does not appear during the cooling process, and therefore rare earth die steel with high impact toughness and high isotropy is obtained.

Abstract: The present disclosure provides rare earth die steel. Mg and B elements are added on the basis of adding rare earth element Y, so that the rare earth element purifies a matrix, and grain boundary occupation by Mg and B is fully utilized to regulate grain network chromium carbides. In addition, the B element can fully improve hardenability of austenite and ensure that non-martensite such as bainite does not appear during the cooling process, and therefore rare earth die steel with high impact toughness and high isotropy is obtained.

Abstract: A compound with anti-drug resistant bacteria activity having the following formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Abstract: A compound with anti-drug resistant bacteria activity having the formula (I): (I) is disclosed. The methods of preparing the compound of formula (I) are also disclosed.

Abstract: A compound with anti-drug resistant bacteria activity having the following formula (I): is disclosed. The methods of preparing the compound of formula (I) are also disclosed.

Abstract: The present invention relates to the technical field of manufacturing of metal materials, and in particular to a 7000-series aluminum alloy wire for additive manufacturing and a preparation method thereof. The wire was prepared by subjecting an Al—Ti—B intermediate alloy containing TiB2 particles generated in situ to severe plastic deformation to obtain an intermediate alloy containing TiB2 nanoparticles having a particle size of 50-1,000 nm or a mixture of two different particles; using the intermediate alloy containing TiB2 nanoparticles as a matrix raw material, adding other metal or intermediate alloy for smelting to obtain an alloy melt; preparing a wire blank with the alloy melt; subjecting the wire blank to hot rolling, drawing, intermediate annealing and surface treatment to obtain an Al—Zn—Mg—Cu alloy wire reinforced by particles at nano scale or submicron scale.

Abstract: A compound with anti-drug resistant bacteria activity having the following formula (I): is disclosed. The methods of preparing the compound of formula (I) are also disclosed.

Abstract: A compound with anti-drug resistant bacteria activity having the formula (I): is disclosed. The methods of preparing the compound of formula (I) are also disclosed.

Abstract: A compound with anti-drug resistant bacteria activity having the following formula (I): is disclosed. The methods of preparing the compound of formula (I) are also disclosed.

Abstract: A compound with anti-drug resistant bacteria activity having the following formula (I): (I) is disclosed. The methods of preparing the compound of formula (I) are also disclosed.

Abstract: A compound with anti-drug resistant bacteria activity having the following formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Abstract: A compound having the formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Abstract: A compound having the formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Abstract: A compound with anti-drug resistant bacteria activity having the following formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Abstract: A compound with anti-drug resistant bacteria activity having the following formula (I) is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Abstract: A compound with anti-drug resistant bacteria activity having the following formula (I) is disclosed. The methods of preparing the compound of formula (I) are also disclosed.

Abstract: A compound having the formula (I): is disclosed. Methods of preparing the compound of formula (I) are also disclosed. The compound of formula (I) can be prepared by reacting a compound of formula (II) with a compound of formula (III) in an organic solvent with EDC (1-ethyl-3-(3-dimethylaminopropyl)carbodiimide). The compound of formula (I) can also be prepared by reacting the compound of formula (II) with the compound of formula (III) in 1-ethyl-3-methylimidazolium hexafluorophosphate as a solvent with silicomolybdic acid as a catalyst.

Abstract: A compound having the formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Abstract: A compound having the formula (I): is disclosed. A method of preparing the compound of formula (I) is also disclosed.

Abstract: The present disclosure provides a process model repairing method based on structure replacement. Firstly, two ordering relationship sets of an event log and a model are obtained by re-defining ordering relationships between activities, and a deviation set recording differences between the event log and the model is obtained; next, the model is repaired according to the deviation set. A selective structure or a sequential structure is changed into a concurrent structure according to the given event log in the present disclosure. The repaired model indicated by a logical Petri net is capable of accurately reflecting a logical relationship between activities. The method of the present disclosure and other model repairing methods are compared through simulation experiments.